Prikaz rezultata 1 – 20 od 20 za pretragu 'Berruti, A', vrijeme upita: 0,04s
Detaljiziraj rezultate
-
1
-
2
-
3
-
4
-
5
-
6
Effect of primary letrozole (LET) vs letrozole plus metronomic cyclophosphamide (LET-CYC) on Treg infiltration in ER plus ve breast cancer. od Fox, S, Generali, D, Berruti, A, Bates, G, Banham, A, Bonardi, S, Milani, M, Dionisio, R, Brizzi, M, Dogliotti, L, Bottini, A, Harris, A
Izdano 2006Conference item -
7
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to pri... od Fox, S, Generali, D, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Mele, T, Dogliotti, L, Bottini, A, Harris, A
Izdano 2011Journal article -
8
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. od Mele, T, Generali, D, Fox, S, Brizzi, M, Bersiga, A, Milani, M, Allevi, G, Bonardi, S, Aguggini, S, Volante, M, Dogliotti, L, Bottini, A, Harris, A, Berruti, A
Izdano 2010Journal article -
9
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients od Mele, T, Generali, D, Fox, S, Brizzi, M, Bersiga, A, Milani, M, Allevi, G, Bonardi, S, Aguggini, S, Volante, M, Dogliotti, L, Bottini, A, Harris, A, Berruti, A
Izdano 2010Journal article -
10
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to pri... od Fox, S, Generali, D, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Mele, T, Dogliotti, L, Bottini, A, Harris, A
Izdano 2011Journal article -
11
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer od Generali, D, Fox, S, Berruti, A, Moore, J, Brizzi, M, Patel, N, Allevi, G, Bonardi, S, Aguggini, S, Bersiga, A, Campo, L, Dogliotti, L, Bottini, A, Harris, A
Izdano 2007Journal article -
12
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer. od Generali, D, Fox, S, Berruti, A, Moore, J, Brizzi, M, Patel, N, Allevi, G, Bonardi, S, Aguggini, S, Bersiga, A, Campo, L, Dogliotti, L, Bottini, A, Harris, A
Izdano 2007Journal article -
13
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. od Generali, D, Buffa, F, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Papotti, M, Dogliotti, L, Bottini, A, Harris, A, Fox, S
Izdano 2009Journal article -
14
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients. od Generali, D, Bates, G, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Dogliotti, L, Banham, A, Harris, A, Bottini, A, Fox, S
Izdano 2009Journal article -
15
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. od Generali, D, Dovio, A, Tampellini, M, Tucci, M, Tedoldi, S, Torta, M, Bonardi, S, Allevi, G, Aguggini, S, Milani, M, Harris, A, Bottini, A, Dogliotti, L, Angeli, A, Berruti, A
Izdano 2008Journal article -
16
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer. od Generali, D, Fox, S, Brizzi, M, Allevi, G, Bonardi, S, Aguggini, S, Milani, M, Bersiga, A, Campo, L, Dionisio, R, Vergoni, F, Giardini, R, Dogliotti, L, Bottini, A, Harris, A, Berruti, A
Izdano 2008Journal article -
17
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer od Allevi, G, Strina, C, Andreis, D, Zanoni, V, Bazzola, L, Bonardi, S, Foroni, C, Milani, M, Cappelletti, MR, Gussago, F, Aguggini, S, Giardini, R, Martinotti, M, Fox, S, Harris, A, Bottini, A, Berruti, A, Generali, D
Izdano 2013Journal article -
18
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer. od Allevi, G, Strina, C, Andreis, D, Zanoni, V, Bazzola, L, Bonardi, S, Foroni, C, Milani, M, Cappelletti, MR, Gussago, F, Aguggini, S, Giardini, R, Martinotti, M, Fox, S, Harris, A, Bottini, A, Berruti, A, Generali, D
Izdano 2013Journal article -
19
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer od Andreis, D, Bonardi, S, Allevi, G, Aguggini, S, Gussago, F, Milani, M, Strina, C, Spada, D, Ferrero, G, Ungari, M, Rocca, A, Nanni, O, Roviello, G, Berruti, A, Harris, A, Fox, S, Roviello, F, Polom, K, Bottini, A, Generali, D
Izdano 2016Journal article -
20
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Managemen... od Berruti, A, Generali, D, Kaufmann, M, Puztai, L, Curigliano, G, Aglietta, M, Gianni, L, Miller, W, Untch, M, Sotiriou, C, Daidone, M, Conte, P, Kennedy, D, Damia, G, Petronini, P, Di Cosimo, S, Bruzzi, P, Dowsett, M, Desmedt, C, Mansel, R, Olivetti, L, Tondini, C, Sapino, A, Fenaroli, P, Tortora, G
Izdano 2011Journal article